CWM Advisors »

Revance Therapeutics shares owned by CWM Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by CWM Advisors from 13F filings

Historical chart of CWM Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by CWM Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by CWM Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $383k 44k 8.79
2023-09-30 $305k 27k 11.47
2023-06-30 $315k 12k 25.31
2023-03-31 $273k 8.5k 32.21
2022-12-31 $236k 13k 18.46
2022-09-30 $208k 7.7k 27.05
2022-06-30 $215k 16k 13.84
2022-03-31 $238k 12k 19.47
2021-12-31 $251k 15k 16.29